The News Review:

- INC Research Appoints Richard Williams as Vice President Regulatory…
- Daily Research News nline appointment no. 225 – printer-friendly…
- New Michael J. Fox Foundation Initiative Will Drive Development of…
- WaterHealth International Announces Agreement with LV Prasad Eye…
- eGov monitor – A Policy Dialogue Platform | Promoting Better Governanc…

INC Research Appoints Richard Williams as Vice President Regulatory…
Carolina Newswire – Carolina Newswire (press release) – Mar 19, 2008
“The company’s continuing investments in innovative processes will help ensure that we are always able to provide our customers with strategic solutions for their regulatory needs. ” Williams brings deep expertise from the pharmaceutical and biotechnology industry as well. Prior to joining INC Research he held senior management positions in clinical research and regulatory affairs for large pharmaceutical companies such as Merck & Co. and Pfizer Inc and smaller successful start-up companies including Vertex Pharmaceuticals Incorporated Pharmavene Inc. and IN Therapeutics (now IkariaTM). With such diversified regulatory experiences he has taken several products through to worldwide marketing approval including blockbuster drugs and cutting-edge technology products in emerging companies.

Daily Research News nline appointment no. 225 – printer-friendly…
Daily Research News nline – Mar 19, 2008
225 Published March 19 2008 Clinipace Clinical research software firm Clinipace has appointed David Levin as VP Marketing responsible for product marketing and management corporate communications and customer experience. Levin previously served in a number of positions in the healthcare industry most recently as VP at MEDSEEK and etrials. Prior to this he was VP of Marketing at MercuryMD which was acquired by the Thomson Corporation in 2006. CE Jeff Williams commented: ‘David brings us a 15-year record of successfully positioning companies and their products within the healthcare industry and delivering positive client satisfaction outcomes. We are entering an exciting time and David will spearhead efforts to bring our message to more life sciences customers.

New Michael J. Fox Foundation Initiative Will Drive Development of…
Earthtimes – Mar 19, 2008
Fox Foundation announced the launch of its Web-based Clinical Assessment Program. Under this initiative the Foundation seeks to drive the creation and testing of Web-based tools that would allow any patient with a personal computer and an Internet connection to participate in clinical research from the comfort of their own home. Historically clinical research in Parkinson’s and other diseases has required patients to travel often several hours or more for in-person interviews examinations and tests. This is a burden for anyone living with a disease and takes an incredible toll on people with PD where unpredictable motor and non-motor effects as well as the efficacy and side effects of medication vary from day to day. "A Web-based clinical assessment can never entirely take the place of face-to-face interactions between patients and researchers" said Katie Hood CE of MJFF. "But as a supplemental measure it could heighten efficiency and help speed progress toward new treatments by increasing for a given trial the amount and breadth of information from which to draw conclusions. "Added Todd Sherer PhD the Foundation’s vice president of research programs: "In addition to increasing the participation of individuals who might otherwise not realistically be able to take part due to travel a Web-based clinical assessment could provide a more complete picture of symptoms by introducing the ability to test certain functions at home and throughout the day.

WaterHealth International Announces Agreement with LV Prasad Eye…
techwhack.com – Mar 19, 2008
(WHI) today announced the launch of a WaterHealth Centres at the LV Prasad Eye Institute (LVPEI) facility in Kismatpur. WaterHealth also announced that LVPEI India?s leading Eye Care Clinical Research and Academic Institution will use WaterHealth systems in its [Bubhaneshwar Vishkhapatnam and Hyderabad] locations. ?We are extremely proud that a notable organization such as LVPEI has chosen to join forces with WaterHealth? said Dr. Tralance Addy CE of WaterHealth International. ?LV Prasad Eye Institute and WaterHealth are united in our commitment to providing top quality products and services in a manner affordable to everyone. ??Improving the quality of life and health by providing clean and safe water has been WaterHealth?s foremost priority? said Sudesh Menon CE of WaterHealth India.

eGov monitor – A Policy Dialogue Platform | Promoting Better Governanc…
eGov monitor – Mar 19, 2008
We want to create a world-class health research system in which the NHS supports people conducting leading-edge research and gives patients better access to ground-breaking new medicines and treatments. ""The new Biomedical Research Centre in Manchester will strengthen our drive to put the UK at the forefront of vital health research and contribute to the nation’s international competitiveness as a major component of our knowledge economy. ""The investment the Government is making in this new Centre will also provide a major boost to innovation and economic development in Manchester and the North West. "Central Manchester and Manchester Children’s University Hospitals NHS Trust chief executive Mike Deegan said: "This momentous decision means we can now embark on the final phase of a massive transformation project. Alongside our £500m investment in new hospital buildings and facilities the Trust and University will be able to deliver world class research that benefits patients both locally and globally. We will make sure that the communities which surround the BRC also get additional benefit from jobs and new commercial opportunities. "Professor Alan Gilbert President and Vice Chancellor of The University of Manchester said: "This announcement recognises the quality of the biomedical research currently being conducted in Manchester and the excellent partnership that has been forged between the University and the Trust to undertake world class clinical research.